Monica Sarria Nunez

Title: Innovator Monica Sarria Nunez: Pioneering Methods to Combat Flavivirus Infections

Introduction

Monica Sarria Nunez, an esteemed inventor based in Havana, Cuba, has made a significant contribution to the field of biotechnology. Her research focuses on developing innovative methods to combat viral infections, particularly those caused by flaviviruses. This article explores her notable patent and her professional journey.

Latest Patents

Monica Sarria Nunez holds a patent for a groundbreaking invention titled "Method to Block the Infection by Flaviviruses, Molecules and Uses." This invention presents a novel approach to blocking the infection of cells by the dengue virus. It involves disrupting the direct interaction between the viral envelope protein and a cellular receptor, as well as its indirect interaction through a carrier protein. The cellular receptor identified in her method is the alpha-2 macroglobulin receptor, commonly known as the low-density receptor-related protein or CD91, while the carrier protein used is human alpha-2 macroglobulin. This innovation has the potential to enhance therapeutic strategies against dengue virus infections.

Career Highlights

Monica currently works at the Center for Genetic Engineering and Biotechnology (Centro De Ingenieria Genetica Y Biotecnologia), a leading institution dedicated to advanced research in genetics and biotechnology. Throughout her career, she has demonstrated a commitment to developing innovative solutions that address pressing health challenges, particularly those posed by viral diseases.

Collaborations

In her pursuit of scientific advancement, Monica has collaborated with talented colleagues, including Vivian Huerta Galindo and Glay Chinea Santiago. These partnerships have fostered a creative research environment and facilitated the exchange of ideas, propelling their collective efforts in combating viral infections.

Conclusion

Monica Sarria Nunez stands out as an innovative force in the biotechnological landscape. Her patent for a method to inhibit flavivirus infections illustrates her commitment to advancing medical science and improving public health. With continued support and collaboration, her work holds promise for significant impacts in the field of virology and beyond.